Clinica Integral Internacional de Oncologia S. de R.L. de C.V.

Puebla City 72530

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Locally Advanced or Unresectable Metastatic Breast Cancer, Non-small Cell Lung Cancer, Stage IV Breast Cancer

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling